COVID-19 pandemic
The Public Health Agency of Sweden temporarily suspends the use of the Oxford-AstraZeneca vaccine pending a review from the European Medicines Agency following reports on abnormal blood clotting in vaccinated people.
Sources: NPR
Changes
- The Public Health Agency of Sweden temporarily suspends the use of the Oxford-AstraZeneca vaccine pending review from the European Medicines Agency following reports on abnormal blood clotting amongst the vaccinated people.
- The Public Health Agency of Sweden temporarily suspends the use of the Oxford-AstraZeneca vaccine pending a review from the European Medicines Agency following reports on abnormal blood clotting in vaccinated people.